Cholestyramine Light Powder, For Suspension
NDC Package 42806-269-98
Package Information
Cholestyramine Light powders is 1) Cholestyramine for Oral Suspension, USP Light powder is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. This formulation utilizes a powder, for suspension delivery system. Marketed by Epic Pharma, Llc, this product is identified by NDC 42806-269 and is authorized under FDA application ANDA074558.
Identification & Billing
- RxCUI: 1801279 - cholestyramine Sugar-Free 4 GM Powder for Oral Suspension
- RxCUI: 1801279 - Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 42806 - Epic Pharma, Llc
- 42806-269 - Cholestyramine Light
- 42806-269-98 - 5.7 g in 1 POUCH
- 42806-269 - Cholestyramine Light
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42806-269-98 identifies a specific commercial package of 5.7 g in 1 pouch of Cholestyramine Light, a human prescription drug labeled by Epic Pharma, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This powder, for suspension is formulated for oral use and contains cholestyramine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Epic Pharma, Llc on December 15, 2021. The current certification is valid through December 31, 2027.
How is this Epic Pharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42806026998. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.